← Back to Analyst Consensus 
CRSP Buy
CRISPR Therapeutics AG
Current Price —
Implied Upside —
Analysts 28
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Aug 31, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Aug 31, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Aug 25, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Aug 4, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 6, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| May 13, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| May 6, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 17, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Feb 17, 2026 | Chardan Capital | maintain | Buy → Buy | $76 | 47% |
| Feb 13, 2026 | TD Cowen | maintain | Hold → Hold | $45 | 54% |
| Feb 13, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $74 | 58% |
| Feb 13, 2026 | Needham | maintain | Buy → Buy | $82 | 50% |
| Jan 30, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $80 | 47% |
| Dec 23, 2025 | Needham | reiterate | Buy → Buy | $80 | 50% |
| Dec 23, 2025 | Citizens | reiterate | Market Outperform → Market Outperform | $86 | 47% |
| Nov 26, 2025 | Chardan Capital | maintain | Buy → Buy | $74 | 47% |
| Nov 12, 2025 | Citigroup | maintain | Buy → Buy | $77 | 54% |
| Nov 11, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $50 | 55% |
| Nov 11, 2025 | Baird | maintain | Neutral → Neutral | $44 | 55% |
| Nov 10, 2025 | Needham | maintain | Buy → Buy | $80 | 50% |
| Oct 17, 2025 | B of A Securities | maintain | Buy → Buy | $93 | 53% |
| Oct 10, 2025 | Needham | reiterate | Buy → Buy | $81 | 50% |
| Sep 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Sep 18, 2025 | JP Morgan | initiate | — → Overweight | $70 | 54% |
| Aug 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $80 | 44% |
| Aug 6, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $56 | 53% |
| Aug 5, 2025 | Chardan Capital | maintain | Buy → Buy | $82 | 47% |
| Aug 5, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $42 | 55% |
| Jul 22, 2025 | B of A Securities | maintain | Buy → Buy | $78 | 53% |
| Jul 8, 2025 | Needham | reiterate | Buy → Buy | $81 | 50% |
| Jun 27, 2025 | Clear Street | downgrade | Buy → Hold | $45 | 48% |
| Jun 27, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $105 | 54% |
| Jun 27, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $86 | 53% |
| Jun 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| Jun 26, 2025 | Needham | reiterate | Buy → Buy | $81 | 50% |
| Jun 26, 2025 | Chardan Capital | maintain | Buy → Buy | $82 | 47% |
| May 21, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $86 | 53% |
| May 20, 2025 | Needham | reiterate | Buy → Buy | $81 | 50% |
| May 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $65 | 44% |
| May 9, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $42 | 53% |
| May 8, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $47 | 54% |
| May 7, 2025 | Needham | maintain | Buy → Buy | $81 | 50% |
| May 7, 2025 | Chardan Capital | maintain | Buy → Buy | $82 | 47% |
| Apr 9, 2025 | Needham | reiterate | Buy → Buy | $84 | 50% |
| Feb 19, 2025 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $0 | 50% |
| Feb 18, 2025 | Citigroup | maintain | Buy → Buy | $82 | 54% |
| Feb 14, 2025 | Morgan Stanley | maintain | Underweight → Underweight | $32 | 54% |
| Feb 14, 2025 | Evercore ISI Group | upgrade | In-Line → Outperform | $99 | 58% |
Price Target Trend
Jun 10, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days